Skip to main content
Clinical Trials/JPRN-UMIN000027783
JPRN-UMIN000027783
Completed
未知

An interventional study to assess patient-reported outcome measures in bradalumab treated patients with moderate to severe plaque psoriasis in Japan - PROMs in brodalumab treated patients with psoriasis in Japan

Kyowa Hakko Kirin Co., Ltd0 sites74 target enrollmentJune 16, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyowa Hakko Kirin Co., Ltd
Enrollment
74
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2017
End Date
March 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kyowa Hakko Kirin Co., Ltd

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients with psoriatic erythroderma, pustular psoriasis and guttate psoriasis at the time of informed concent. 2\)Patients with a severe infection or active tuberculosis at the time of informed concent. 3\)Patients who are judged by the investigator or subinvestigator to be unsuitable for participation in this study. 4\)Patients with joint symptoms at enrollment.

Outcomes

Primary Outcomes

Not specified

Similar Trials